Consumer medicine information

Panadol Tablets, Panadol Mini Caps

Paracetamol

BRAND INFORMATION

Brand name

Panadol

Active ingredient

Paracetamol

Schedule

S2 | Unscheduled | S3

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Panadol Tablets, Panadol Mini Caps.

What is in this leaflet

This leaflet answers some common questions about PANADOL. It does not contain all the available information. It does not take the place of talking to your pharmacist or doctor.

All medicines have risks and benefits.

If you have any concerns about taking this medicine, ask your pharmacist or doctor.

Keep this leaflet with the medicine. You may need to read it again.

What PANADOL is used for

The active ingredient in these medicines is paracetamol.

Paracetamol is used for the fast effective temporary relief of pain and discomfort associated with various pain states including:

  • Headache
  • Muscular aches
  • Period pain
  • Arthritis/Osteoarthritis
  • Toothache
  • Migraine headache
  • Colds and flu symptoms
  • Tension headache
  • Sinus pain/headache
  • Backache

Paracetamol also reduces fever.

Paracetamol works to stop the pain messages from getting through to the brain. It also acts in the brain to reduce fever.

Ask your pharmacist or doctor if you have any questions about this medicine. Your pharmacist or doctor may have given it for another reason.

Before you use PANADOL

Do not take more than the recommended dose as it may cause serious harm to your liver.

When you must not use it

Do not use PANADOL if you have an allergy to:

  • Any of the ingredients listed at the end of this leaflet.

Do not use this medicine if you are taking any other prescription or non-prescription medicines containing paracetamol to treat pain, fever, symptoms of cold and flu, or to aid sleep.

Always read and follow the label.

Do not take this medicine after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering. If it has expired or is damaged, return it to your pharmacist for disposal.

If you are not sure whether you should start using this medicine, talk to your pharmacist or doctor.

Before you start to use it

Tell your pharmacist or doctor if you have or have had any of the following medical conditions:

  • Liver or kidney problems
  • Are underweight or malnourished
  • Regularly drink alcohol
    You may need to avoid using this product altogether or limit the amount of paracetamol that you take.
  • You have a severe infection, are severely malnourished or are a chronic heavy alcohol user as this may increase the risk of metabolic acidosis. Signs of metabolic acidosis include:
    - deep, rapid, difficult breathing
    - feeling sick (nausea), being sick (vomiting)
    - loss of appetite
    Contact a doctor immediately if you get a combination of these symptoms.

Please see your doctor if your symptoms do not improve.

Keep out of sight and reach of children.

Ask your pharmacist or doctor about using paracetamol if you are pregnant or plan to become pregnant, or breastfeeding. Paracetamol may be used during pregnancy and if you are breastfeeding but you should always consult your doctor first.

Consider taking the lowest effective dose for the shortest period of time.

If you have not told your pharmacist or doctor about any of the above, tell them before you use PANADOL.

Using other medicines

Tell your pharmacist or doctor if you are using any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop.

Some medicines and paracetamol may interfere with each other. These include:

  • Warfarin or similar medicines used to thin the blood
  • Metoclopramide, a medicine used to control nausea and vomiting
  • Medicines used to treat epilepsy or fits
  • Chloramphenicol, an antibiotic used to treat ear and eye infections
  • Alcohol
  • Probenecid, a medicine used to treat gout or sometimes given with an antibiotic
  • Cholestyramine, a medicine used to treat high cholesterol levels in the blood

Your pharmacist and doctor will have more information on these and other medicines to be careful with or avoid while using this medicine.

How to use PANADOL

Follow all directions given to you by your pharmacist or doctor carefully. They may differ from the information contained in this leaflet.

If you do not understand the instructions on the box/bottle, ask your pharmacist or doctor for help.

Do not exceed the stated dose.

Use the smallest dose that you need to treat your symptoms and use the medicine for the shortest period of time necessary.

How much to use

PANADOL Tablets

Adults and children aged 12 years and over: Take 1 to 2 tablets every four to six hours as needed. Do not take more than 8 tablets in 24 hours.

Children 7 to 12 years: Take ½ to 1 tablet every four to six hours as needed. Do not take more than 4 tablets in 24 hours.

Not recommended in children under 7 years.

PANADOL Mini Caps

Adults and children aged 12 years and over: Take 1 to 2 caplets every four to six hours as needed. Do not take more than 8 caplets in 24 hours.

Children 7 to 12 years: Take 1 caplet every four to six hours as needed. Do not take more than 4 caplets in 24 hours.

Do not use in children under 7 years.

How to use it

PANADOL Tablets and Mini Caps

Swallow with water or other fluid.

How long to use it

PANADOL Tablets and Mini Caps

Adults:

Only take paracetamol for a few days at a time unless your doctor tells you to take it for longer.

Children 7 to 17 years:

Only give paracetamol to children for up to 48 hours unless a doctor has told you to give it for longer.

If you use too much (overdose)

Immediately telephone your doctor or the Poisons Information Centre (telephone 13 11 26 for Australia, 0800 764 766 for New Zealand) for advice, or go to Accident and Emergency at the nearest hospital, if you think that you or anyone else may have taken too much PANADOL. Do this even if there are no signs of discomfort or poisoning because of the risk of delayed, serious liver damage/failure if left untreated. You may need urgent medical attention.

While you are using PANADOL

Things you must do

Talk to your pharmacist or doctor if your symptoms do not improve. Your pharmacist or doctor will assess your condition and decide if you should continue to take the medicine.

Things you must not do

Children:

Do not give paracetamol for more than 48 hours unless a doctor has told you to.

Adults:

Do not use for more than a few days at a time unless your doctor tells you to.

Do not take more than the recommended dose unless your doctor tells you to.

Do not use PANADOL to treat any other complaints unless your pharmacist or doctor tells you to.

Things to be careful of

Only drink small quantities of alcohol (beer, wine or spirits) while using paracetamol. Drinking large quantities of alcohol while taking paracetamol may increase the risk of liver side effects.

Side effects

Tell your pharmacist or doctor as soon as possible if you do not feel well while you are using PANADOL.

This medicine helps most people with various types of pain but it may have unwanted side effects. All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical attention if you get some of the side effects.

Do not be alarmed by the following lists of side effects. You may not experience any of them.

Ask your pharmacist or doctor to answer any questions you may have.

If any of the following happen, stop use and tell your doctor immediately or go to Accident and Emergency at your nearest hospital:

  • Shortness of breath
  • Wheezing or difficulty breathing
  • Swelling of the face, lips, tongue, throat or other parts of the body
  • Allergic skin reaction such as rash, peeling, itching or hives
  • Mouth ulcers
  • Unexplained bruising or bleeding

The above list includes very serious side effects of your medicine. You may need urgent medical attention or hospitalisation. These side effects are very rare for low doses of this medicine and when used for a short period of time.

Tell your pharmacist or doctor if you notice anything that is making you feel unwell.

Other side effects not listed above may also occur in some people.

After using PANADOL

Storage

Keep your medicine in the original pack until it is time to take it.

Keep your medicine in a cool dry place where the temperature stays below 30°C for PANADOL Tablets and below 25°C for PANADOL Mini Caps.

Do not store PANADOL or any other medicine in the bathroom or near a sink. Do not leave it on a window sill or in the car. Heat and dampness can destroy some medicines.

Keep it where children cannot reach it. A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.

Disposal

Ask your pharmacist what to do with any medicine that is left over, or if the expiry date has passed.

Product description

What it looks like

PANADOL Tablets are a white, film-coated round tablet. They are marked "PANADOL" on one side and have a break bar on the other side.

PANADOL Mini Caps are a capsule-shaped tablet with a gelatin coating. One half is green and the other half is white.

Ingredients

PANADOL Tablets contain 500 mg of paracetamol as the active ingredient.

They also contain:

  • Starch-pregelatinised maize
  • Starch-maize
  • Talc-purified
  • Stearic acid
  • Hypromellose
  • Povidone
  • Glycerol triacetate
  • Potassium sorbate
  • Carnauba wax

Contains potassium sorbate as a preservative.

PANADOL Mini Caps contain 500 mg of paracetamol as the active ingredient.

They also contain:

  • Gelatin capsules hard
  • Starch-pregelatinised maize
  • Croscarmellose sodium
  • Povidone
  • Stearic acid
  • Hypromellose
  • Titanium dioxide
  • Quinoline yellow
  • Brilliant blue FCF
  • Allura red AC

Manufacturer/ Supplier

Haleon Australia
Level 48, 8 Parramatta Square,
10 Darcy Street, Parramatta NSW
2150 and Auckland, New Zealand

AUST R 13591 (PANADOL Tablets)

AUST R 81007 (PANADOL Mini Caps)

Date of Preparation Jan 2025

Trademarks are owned by or licensed to Haleon.

Published by MIMS March 2025

BRAND INFORMATION

Brand name

Panadol

Active ingredient

Paracetamol

Schedule

S2 | Unscheduled | S3

 

1 Name of Medicine

Paracetamol.

2 Qualitative and Quantitative Composition

Panadol Tablets.

Active ingredient: Paracetamol 500 mg/tablet.
Each tablet contains potassium sorbate as a preservative, which may cause allergic reactions.

Panadol Mini Caps.

Active ingredient: Paracetamol 500 mg/mini cap.

Excipients.

For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Panadol Tablets.

White, film-coated tablet with bevelled edge, shallow convex, double radius 1.27 cm diameter. Marked Panadol on one side and with a break bar on the reverse side.

Panadol Mini Caps.

Capsule shaped tablet with a gelatin coating which is one half green and the other half white.

4 Clinical Particulars

4.1 Therapeutic Indications

For fast effective temporary relief of pain and discomfort associated with headache, muscular aches, period pain, arthritis/osteoarthritis, toothache, migraine headache, cold and flu symptoms, tension headache, sinus pain/headache and backache. Reduces fever.

4.2 Dose and Method of Administration

See Table 1.

General dosage instructions.

Adults.

Do not use for more than a few days at a time without medical advice.

Children 7-17 years.

Do not use for more than 48 hours except on medical advice.
Should not be used with other paracetamol-containing products.
Minimum dosing interval: 4 hours.
If symptoms persist, medical advice must be sought.
Do not exceed the stated dose.
The lowest dose necessary to achieve efficacy should be used for the shortest duration of treatment.
Minimum dosing interval: 4 hours.
Maximum daily dose for children 12 years of age to adults: 4,000 mg.
Keep out of sight and reach of children.

4.3 Contraindications

Contraindicated in patients with a previous history of hypersensitivity to paracetamol or to any of the excipients.

4.4 Special Warnings and Precautions for Use

Identified precautions.

Contains paracetamol. Do not use with any other paracetamol-containing products. The concomitant use with other products containing paracetamol may lead to an overdose.
Paracetamol overdose may cause liver failure which may require liver transplant or lead to death.
If symptoms persist, medical advice must be sought.
Keep out of sight and reach of children.

Use in hepatic impairment.

Paracetamol should be used with caution in patients with impaired liver function: Underlying liver disease increases the risk of paracetamol-related liver damage.
Patients who have been diagnosed with liver impairment must seek medical advice before taking this medication.
Cases of hepatic dysfunction/failure have been reported in patients with depleted glutathione levels, such as those who are severely malnourished, anorexic, have a low body mass index, are chronic heavy users of alcohol or have sepsis.
In patients with glutathione depleted states the use of paracetamol may increase the risk of metabolic acidosis.

Use in renal impairment.

Paracetamol should be used with caution in patients with impaired kidney function: Administration of paracetamol to patients with moderate to severe renal impairment may result in accumulation of paracetamol conjugates.
Patients who have been diagnosed with kidney impairment must seek medical advice before taking this medication.

Use in the elderly.

No data available.

Paediatric use.

Panadol Tablets and Panadol Mini Caps are not recommended for children under seven years of age.

Effects on laboratory tests.

No data available.

4.5 Interactions with Other Medicines and Other Forms of Interactions

The following interactions with paracetamol have been noted.
The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol with increased risk of bleeding; occasional doses have no significant effect. Anticoagulant dosage may require reduction if paracetamol and anticoagulants are taken for a prolonged period of time.
Paracetamol absorption is increased by substances that increase gastric emptying, e.g. metoclopramide.
Paracetamol absorption is decreased by substances that decrease gastric emptying, e.g. propantheline, antidepressants with anticholinergic properties, and narcotic analgesics.
Paracetamol may increase chloramphenicol concentrations.
The risk of paracetamol toxicity may be increased in patients receiving other potentially hepatotoxic drugs or drugs that induce liver microsomal enzymes such as alcohol and anticonvulsant agents.
Paracetamol excretion may be affected and plasma concentrations altered when given with probenecid.
Cholestyramine reduces the absorption of paracetamol if given within 1 hour of paracetamol.

4.6 Fertility, Pregnancy and Lactation

Effects on fertility.

No data available.
(Category A)
As with the use of any medicine during pregnancy, pregnant women should seek medical advice before taking paracetamol. The lowest effective dose and shortest duration of treatment should be considered.
Paracetamol has been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the foetus having been observed.
 Paracetamol is excreted in small amounts (< 0.2%) in breast milk. Maternal ingestion of paracetamol in usual analgesic doses does not appear to present a risk to the breastfed infants. Available published data do not contraindicate breastfeeding.

4.7 Effects on Ability to Drive and Use Machines

The effects of this medicine on a person's ability to drive and use machines were not assessed as part of its registration.

4.8 Adverse Effects (Undesirable Effects)

Reporting suspected adverse effects.

Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at www.tga.gov.au/reporting-problems.
Adverse events from historical clinical trial data are both infrequent and from small patient exposure. Accordingly, events reported from extensive post-marketing experience at therapeutic/labelled doses and considered attributable are tabulated below by System Organ Class and frequency.
The following convention has been utilised for the classification of undesirable effects: very common (≥ 1/10), common (≥ 1/100, < 1/10), uncommon (≥ 1/1,000, < 1/100), rare (≥ 1/10,000, < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from available data).
Adverse event frequencies have been estimated from spontaneous reports received through post-marketing data. See Table 2.

4.9 Overdose

If an overdose is taken or suspected, contact the Poisons Information Centre immediately for advice (131 126), or the patient should go to the nearest hospital straight away. This should be done even if they feel well because of the risk of delayed, serious liver damage.

Treatment.

Immediate medical management is required in the event of an overdose, even if the symptoms of overdose are not present.
Paracetamol overdose may cause liver failure which may require liver transplant or lead to death. Acute pancreatitis has been observed, usually with hepatic dysfunction and liver toxicity.
Administration of N-acetylcysteine may be required.
Activated charcoal may reduce absorption of paracetamol if given within one hour after oral ingestion. In patients who are not fully conscious or have impaired gag reflex, consideration should be given to administering activated charcoal via a nasogastric tube, once the airway is protected.

5 Pharmacological Properties

5.1 Pharmacodynamic Properties

Mechanism of action.

Paracetamol is a para-aminophenol derivative that exhibits analgesic and anti-pyretic activity. It does not possess anti-inflammatory activity. Its mechanism of action is believed to include inhibition of prostaglandin synthesis, primarily within the central nervous system. It is given by mouth or rectally (suppositories) for mild to moderate pain and to reduce fever.

Clinical trials.

No data available.

5.2 Pharmacokinetic Properties

Absorption.

Paracetamol is rapidly and almost completely absorbed from the gastrointestinal tract with peak plasma concentration occurring about 10 to 60 minutes after oral administration. Food intake delays paracetamol absorption. Following rectal administration of paracetamol, there is considerable variation in peak plasma concentrations attained, and time to reach peak plasma concentrations is substantially longer than after oral administration.

Distribution.

Paracetamol is distributed into most body tissues. Binding to the plasma proteins is minimal at therapeutic concentrations but increases with increasing doses.

Metabolism.

Paracetamol is metabolised extensively in the liver and excreted in the urine mainly as inactive glucuronide and sulphate conjugates.
The metabolites of paracetamol include a minor hydroxylated intermediate which has hepatotoxic activity. This intermediate metabolite is detoxified by conjugation with glutathione. However, it can accumulate following paracetamol overdosage (more than 150 mg/kg or 10 g total paracetamol ingested) and, if left untreated, can cause irreversible liver damage.
Paracetamol is metabolised differently by infants and children compared to adults, the sulphate conjugate being predominant.

Excretion.

Paracetamol is excreted in the urine mainly as the inactive glucuronide and sulphate conjugates. Less than 5% is excreted unchanged. The elimination half-life varies from about one to three hours. Approximately 85% of a dose of paracetamol is excreted in urine as free and conjugated paracetamol within 24 hours after ingestion.

5.3 Preclinical Safety Data

Genotoxicity.

No data available.

Carcinogenicity.

No data available.

6 Pharmaceutical Particulars

6.1 List of Excipients

Panadol Tablets.

Excipients: Starch - pregelatinised maize, Starch - maize, Talc - purified, Stearic acid, Hypromellose, Povidone, Glycerol triacetate, Potassium sorbate, Carnauba wax.

Panadol Mini Caps.

Excipients: Gelatin capsules hard, Starch - pregelatinised maize, Croscarmellose sodium, Povidone, Stearic acid, Hypromellose, Titanium dioxide, Quinoline yellow, Brilliant blue FCF, Allura red AC.

6.2 Incompatibilities

Incompatibilities were either not assessed or not identified as part of the registration of this medicine.

6.3 Shelf Life

In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.

6.4 Special Precautions for Storage

Panadol Tablets.

Store below 30°C.

Panadol Mini Caps.

Store below 25°C.

6.5 Nature and Contents of Container

Panadol Tablets.

Blister packs of 2, 12, 16, 20, 48, 50 and 100 tablets.

Panadol Mini Caps.

Blister packs of 12, 16, 20, 48 and 96 tablets.

6.6 Special Precautions for Disposal

In Australia, any unused medicine or waste material should be disposed of in accordance with local requirements.

6.7 Physicochemical Properties

Chemical structure.


CAS number.

103-90-2.

7 Medicine Schedule (Poisons Standard)

Packs of 16 tablets or Mini Caps or less.

Unscheduled.

Packs larger than 16 tablets or Mini Caps but less than 50 tablets or Mini Caps.

S2, Pharmacy Medicine.

Packs larger than 50 tablets or Mini Caps.

S3, Pharmacist Only Medicine.

Summary Table of Changes